Taking stock and moving forward
A new publication policy for the transplantation society congress in year 2002
Dedication to the memory of Felix T. Rapaport
Dedication to the memory of Felix T. Rapaport (1929–2001)
Thank you
Introduction of the president of the society, Carl G. Groth
Presidential address 2002: organ transplantation as a patient service worldwide
Medawar prize ceremony 2002, introduction
Introduction of Rene KÜSS
Acceptance speech by Rene KÜSS
Introduction of Joseph E. Murray
Acceptance speech by Joseph E. Murray
Introduction of Georges Matheé
Response by Georges Mathé
FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts
Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator1
Interleukin-13 gene transfer protects rat livers from antigen-independent injury induced by ischemia and reperfusion1
Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates1
Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs
Mechanisms of bioprosthetic heart valve calcification1
Role of CD4+CD25+ regulatory T cells from naive host thymus in the induction of acquired transplant tolerance by immunization with allo-major histocompatibility complex peptide.1
CD45RB-targeting strategies for promoting long-term allograft survival and preventingchronic allograft vasculopathy1
Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy
Effects of hemodynamic instability on brain death-induced prepreservation liver damage1
Synergistic tolerance induced by LF15-0195 and anti-CD45RB monoclonal antibody through suppressive dendritic cells1
Monotherapy with LF 15-0195, an analogue of 15-deoxyspergualin, significantly prolongs renal allograft survival in monkeys1
Use of older controlled non-heart-beating donors for liver transplantation
Internet-based intervention to promote organ donor registry participation and family notification1, 2
Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine
Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients
Assessment of renal graft function by perioperative monitoring of cortical microcirculation in kidney transplantation.1
Split-liver transplantation eliminates the need for living-donor liver transplantation in children with end-stage cholestatic liver disease
Complement activation in early protocol kidney graft biopsies after living-donor transplantation1
Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months1
Prognostic significance of free radicals: mediated injury occurring in the kidney donor
Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation
Dual-kidney transplants: long-term results1
Cognitive performance of children who have undergone liver transplantation
A schema for histologic grading of small intestine allograft acute rejection
Expression of MUC2 and MUC4 proteins and cytokines: early markers of intestinal graft rejection1, 2
Predicting long-term kidney graft survival: can new trials be performed?1, 2
Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study1
Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches
Underutilization of pancreas donors
Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trial1
WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation1
Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation1, 2
Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation1
Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation
CD103 mRNA levels in urinary cells predict acute rejection of renal allografts1
Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications1, 2
Adverse outcome of human islet-allogeneic blood interaction1, 2
Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies
Location of in-house organ procurement organization staff in level I trauma centers increases conversion of potential donors to actual donors
Hormonal resuscitation yields more transplanted hearts, with improved early function1
Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration1
High diversity of non-human leukocyte antigens in transplant-associated coronary artery disease1
Differential early posttransplant cytokine responses in living and cadaver donor renal allografts
Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors1
Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules1
An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection1
Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway1
Induction of apoptosis in human lymphocytes by human anti-HLA class I antibodies
Non-heart-beating versus cadaveric and living-donor livers: differences in inflammatory markers before transplantation
Keratinocytes Induce Local Tolerance to Skin Graft by Activating Interleukin-10–Secreting T Cells in the Context of Costimulation Molecule B7-H11
Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1
The frequency of interferon-gproducing cells reflects alloreactivity against minor histocompatibility antigens
A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients1, 2
Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats
Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice1